<code id='70C62FC002'></code><style id='70C62FC002'></style>
    • <acronym id='70C62FC002'></acronym>
      <center id='70C62FC002'><center id='70C62FC002'><tfoot id='70C62FC002'></tfoot></center><abbr id='70C62FC002'><dir id='70C62FC002'><tfoot id='70C62FC002'></tfoot><noframes id='70C62FC002'>

    • <optgroup id='70C62FC002'><strike id='70C62FC002'><sup id='70C62FC002'></sup></strike><code id='70C62FC002'></code></optgroup>
        1. <b id='70C62FC002'><label id='70C62FC002'><select id='70C62FC002'><dt id='70C62FC002'><span id='70C62FC002'></span></dt></select></label></b><u id='70C62FC002'></u>
          <i id='70C62FC002'><strike id='70C62FC002'><tt id='70C62FC002'><pre id='70C62FC002'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:3558
          Wraparound views of downtown Boston enrich the employees at the new offices of Foundation Medicine in the Seaport District.
          Lane Turner/Globe Staff

          Contemporary paintings by artists who have overcome homelessness or disabilities greet visitors in the lobby. Upstairs in the cafeteria, employees order lunches served by local restaurants, including barbecued pulled pork sandwiches from Pennypacker’s. On the top floor, workers can savor a panoramic view of the Seaport District and downtown Boston.

          This is the new headquarters of Foundation Medicine, a biotechnology firm that is consolidating its 1,100 Massachusetts employees into a new 16-story brick masonry building at 400 Summer St. Foundation, established in 2010 and later acquired by the Swiss drug giant Roche, had workers scattered among four locations, including its former headquarters in Cambridge.

          advertisement

          About 800 workers have moved into the 630,000-square-foot building, which is kitty-corner from the Boston Convention and Exhibition Center, with the remaining 300 expected to arrive by early next year. No one seems happier about the long-planned consolidation than Dan Malarek, a 17-year veteran of Roche who became Foundation’s chief executive in December.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more
          Experts study whether long Covid risk adds up with each reinfection
          Experts study whether long Covid risk adds up with each reinfection

          AstudyfromZiyadAl-Aly,clinicalepidemiologistatWashingtonUniversityinSt.Louis,showedthatvaccinationap

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          Bristol Myers buys into radiopharmaceuticals with RayzeBio

          CourtesyBristolMyersSquibbBristolMyersSquibbwillpay$4.1billionforRayzeBio,thecompaniessaidTuesday,bu